Methods and compositions for treating a patient for a condition selected from the group consisting of obesity or diabetes, or a combination thereof, are provided herein. A method includes administering to the patient a compound including a histone acetyltransferase inhibitor (iHAT), or an IgF-1 derivative, and a pharmaceutically acceptable carrier.
